Skip to content
10-Q

Quarterly Report

PHARMAGREEN BIOTECH INC. PHBI

0001477932-23-006115

← back to feed
Filed
Aug 14, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Aug 14, 2023 501.46M sh
Operating Cash Flow Q3 2023 · Jun 30, 2023 −$46.25K
Operating Cash Flow Q3 2023 · Jun 30, 2022 −$334.31K
Stockholders Equity Q3 2023 · Jun 30, 2023 −$2.1M
Stockholders Equity Q3 2023 · Sep 30, 2022 −$1.78M
Current Liabilities Q3 2023 · Jun 30, 2023 $2.17M
Current Liabilities Q3 2023 · Sep 30, 2022 $1.91M
Total Liabilities Q3 2023 · Jun 30, 2023 $2.29M
Total Liabilities Q3 2023 · Sep 30, 2022 $2.03M
Current Assets Q3 2023 · Jun 30, 2023 $51.46K
Current Assets Q3 2023 · Sep 30, 2022 $208.97K
Total Assets Q3 2023 · Jun 30, 2023 $140.31K
Total Assets Q3 2023 · Sep 30, 2022 $208.97K
Sga Expense Q3 2023 · Jun 30, 2023 −$3.26K
Sga Expense Q3 2023 · Jun 30, 2023 $28.92K
Sga Expense Q3 2023 · Jun 30, 2022 $16.35K
Sga Expense Q3 2023 · Jun 30, 2022 $64.46K
Net Income Q3 2023 · Jun 30, 2023 −$162.93K
Net Income Q3 2023 · Jun 30, 2023 −$390.29K
Net Income Q3 2023 · Jun 30, 2022 $251.94K
Net Income Q3 2023 · Jun 30, 2022 −$765.08K
Net Income Q3 2023 · Dec 31, 2021 $18.72K
Gross Profit Q3 2023 · Jun 30, 2023 $208
Gross Profit Q3 2023 · Jun 30, 2023 $186
Gross Profit Q3 2023 · Jun 30, 2022 $0
Gross Profit Q3 2023 · Jun 30, 2022 $0
Cost Of Revenue Q3 2023 · Jun 30, 2023 $389
Cost Of Revenue Q3 2023 · Jun 30, 2023 $1.37K
Cost Of Revenue Q3 2023 · Jun 30, 2022 $0
Cost Of Revenue Q3 2023 · Jun 30, 2022 $0
Revenue Q3 2023 · Jun 30, 2023 $597
Revenue Q3 2023 · Jun 30, 2023 $1.56K
Revenue Q3 2023 · Jun 30, 2022 $0
Revenue Q3 2023 · Jun 30, 2022 $0